tiprankstipranks
Trending News
More News >
IQVIA Holdings Inc (IQV)
NYSE:IQV
US Market

IQVIA Holdings (IQV) Earnings Dates, Call Summary & Reports

Compare
1,024 Followers

Earnings Data

Report Date
Apr 23, 2026
Before Open (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
2.83
Last Year’s EPS
2.7
Same Quarter Last Year
Based on 17 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 05, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
Overall the call presented solid demand recovery (strong bookings, record backlog), healthy revenue and EPS growth, robust cash generation, and constructive FY2026 guidance alongside strategic AI and M&A investments. Offsetting risks discussed included slightly elevated cancellations, margin pressure driven by pass‑throughs and product mix, and elevated leverage with higher interest expense. On balance, management portrayed confidence in secular growth drivers and positioning to monetize AI and integrated offerings.
Company Guidance
IQVIA guided full‑year 2026 revenue of $17.159–$17.359 billion (including ~150 bps from M&A and ~100 bps FX tailwind), adjusted EBITDA of $3.975–$4.25 billion and adjusted diluted EPS of $12.55–$12.85; they expect operating D&A of about $610 million, net interest expense of ~ $760 million (≈$80 million higher versus 2025), an effective tax rate just over 17%, and average diluted shares just over 171 million (assuming FX rates as of Feb 4). On a recast basis by new segments, 2026 Commercial Solutions revenue is expected at $7.2–$7.3 billion (≈7–9% growth) and R&D Solutions at $9.9–$10.0 billion (≈4% growth at midpoint). For Q1 management guided adjusted EBITDA of $920–$940 million and adjusted diluted EPS of $2.77–$2.80.
Full‑Year Revenue and EPS Growth
Full‑year 2025 revenue of $16.31B, up 5.9% reported (4.8% constant currency); full‑year adjusted diluted EPS $11.92, up 7.1% year‑over‑year.
Strong Q4 Revenue and EPS
Q4 revenue of $4.34B, up 10.3% reported and 8.1% at constant currency (acquisitions ~2 points of growth); Q4 adjusted diluted EPS $3.42, up 9.6% year‑over‑year.
R&D Demand Recovery and Bookings
Q4 net bookings over $2.7B, up 7% YoY and 5% sequentially; net book‑to‑bill ratio 1.18; backlog reached a record $32.7B, up 5.3% YoY with $8.3B expected in next‑12‑months revenue.
Cash Generation and Share Repurchases
Full‑year free cash flow ~$2.51B (≈99% of adjusted net income); Q4 operating cash flow $735M and free cash flow $561M; repurchased $1.244B of shares in 2025 at an average price of $159.
Segment Performance – Q4 and Full Year
Q4: Technology & Analytics Solutions $1.821B (+9.8% reported, +7.1% cc); R&D Solutions $2.33B (+9.1% reported, +8.2% cc); CSMS $210M (+18.6% reported, +15.3% cc). Full‑year recast 2025: Commercial Solutions $6.73B; R&D Solutions $9.57B.
2026 Guidance
FY2026 revenue guidance $17.159B–$17.359B (includes ~150 bps M&A and ~100 bps FX tailwind); adjusted EBITDA $3.975B–$4.25B; adjusted diluted EPS $12.55–$12.85.
Strategic AI & Technology Partnerships and Recognition
Named #1 generative AI leader in life sciences by Everest Group; announced AWS as preferred generative AI cloud provider; multi‑year partnership with NVIDIA; deployed >150 AI agents across 30+ use cases.
Targeted M&A and Capability Expansion
2025 acquisitions to expand Phase I capabilities, early‑stage oncology site networks, patient solutions (Federate Technologies) and payer/provider analytics (Cedar Gate ~ $125–$140M revenue and ~$33M adjusted EBITDA in 2024).
Commercial Resilience
Commercial performance robust in Q4: TAS/Commercial revenue growth of 9.8% reported (7.1% cc) for the quarter and Commercial Solutions 2026 guidance implying ~7%–9% growth.
Recognition & Talent
Named one of the world’s most admired companies by Fortune for the ninth consecutive year and #1 in its category for the fifth consecutive year.

IQVIA Holdings (IQV) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

IQV Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 23, 2026
2026 (Q1)
2.83 / -
2.7
Feb 05, 2026
2025 (Q4)
3.40 / 3.42
3.129.62% (+0.30)
Oct 28, 2025
2025 (Q3)
2.98 / 3.00
2.845.63% (+0.16)
Jul 22, 2025
2025 (Q2)
2.77 / 2.81
2.646.44% (+0.17)
May 06, 2025
2025 (Q1)
2.63 / 2.70
2.546.30% (+0.16)
Feb 06, 2025
2024 (Q4)
3.11 / 3.12
2.849.86% (+0.28)
Oct 31, 2024
2024 (Q3)
2.82 / 2.84
2.4914.06% (+0.35)
Jul 22, 2024
2024 (Q2)
2.56 / 2.64
2.438.64% (+0.21)
May 02, 2024
2024 (Q1)
2.49 / 2.54
2.453.67% (+0.09)
Feb 14, 2024
2023 (Q4)
2.82 / 2.84
2.782.16% (+0.06)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

IQV Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 05, 2026
$202.54$180.96-10.65%
Oct 28, 2025
$217.43$218.13+0.32%
Jul 22, 2025
$158.96$187.38+17.88%
May 06, 2025
$152.30$146.20-4.01%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does IQVIA Holdings Inc (IQV) report earnings?
IQVIA Holdings Inc (IQV) is schdueled to report earning on Apr 23, 2026, Before Open (Confirmed).
    What is IQVIA Holdings Inc (IQV) earnings time?
    IQVIA Holdings Inc (IQV) earnings time is at Apr 23, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is IQV EPS forecast?
          IQV EPS forecast for the fiscal quarter 2026 (Q1) is 2.83.